Introduction to Keynote 426 Study
Let's dive into the details surrounding Keynote 426 Study. Dr. Rini elaborates on the results of the
Keynote 426 Study Comprehensive Overview
Brian I. Rini, MD, FASCO, discusses an analysis of clustering from the Elizabeth R. Plimack, MD, MS, discusses the updated findings from the phase 3 Thomas Powles, MBBS, MRCP, MD, of Barts Cancer Institute, London, UK, talks about the rationale and results of the Phase III ...
Brian I. Rini, MD, FASCO, Ingram Professor of Medicine, Department of Medicine, Division of Hematology Oncology, Vanderbilt ...
Summary & Highlights for Keynote 426 Study
- Elizabeth Plimack, MD, MS, Fox Chase Cancer Center, Philadelphia, PA, discusses the updated
- Thomas Powles, MBBS, MRCP, MD, Barts Cancer Institute, London, UK, outlines
- Dr. McKay, Medical Oncologist, Assistant Professor of Medicine, University of California, San Diego, shares outcomes of the ...
- Thomas Powles, MBBS, MRCP, MD, director, Barts Cancer Institute, discusses the rationale for the
- Dr. Zhang, Assistant Professor of Medicine, Duke Cancer Institute, shares outcomes from the
That wraps up our extensive overview of Keynote 426 Study.